Estimated Wasteful Spending on Aducanumab Dispensing in the U.S. Medicare Population

Aducanumab, a weight-dosed Alzheimer ' s drug, is available in two fixed-dose vial sizes. This may result in large amounts of discarded drug and wasteful spending. More-efficient vial sizes could save Medicare money if the drug is approved for widespread use.
Source: RAND Research Health and Health Care - Category: Health Management Authors: Source Type: research